Canopy Biosciences launches CRISPR Complete Gene Editing Kits
ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system.
CRISPR-Cas9 has revolutionized the field of gene editing, allowing researchers to modify DNA more quickly and easily than ever before. The CRISPR Complete Kits offered by Canopy Biosciences combine everything a researcher needs to conduct a CRISPR experiment in a single kit.
Edward Weinstein, PhD, CEO of Canopy Biosciences said, “CRISPR has been a revolutionary technology, however there is a steep learning curve to get it efficiently running in your lab. A researcher has to have a good understanding of everything they’ll need, and then they have to order each individual component piecemeal, often from several different suppliers. The CRISPR Complete kits now offered by Canopy completely change that—for the first time a researcher is able to get everything they need in a single kit, from a single supplier. The new kits will make CRISPR available to more researchers than ever before, which is really exciting.”
Pricing for the kits start at $990 for a gene knockout kit. Kits are available for knockouts, knock-ins, point mutations, and many other project types, and include both design and synthesis of crRNAs, tracrRNA, Cas9 protein, genotyping primers, and donor (for knock-ins and point mutations). To learn more about the kits, visit www.canopybiosciences.com.
About Canopy Biosciences
Canopy Biosciences was formed in 2016, partnering with leading research institutions to turn their discoveries into tangible products and make them available to the entire research community. Canopy Biosciences is headquartered in St. Louis, Missouri, and serves researchers at universities, research institutions and biotechnology and pharmaceutical companies worldwide.
Canopy Biosciences is trademarked by Canopy Biosciences, LLC.
SOURCE Canopy Biosciences
CONTACT: Kevin Gamber, (314)-662-9987, kevin.gamber@canopybiosciences.com
RELATED LINKS
http://www.canopybiosciences.com
